Refine by MP, party, committee, province, or result type.

Results 241-255 of 262
Sorted by relevance | Sort by date: newest first / oldest first

Health committee  As you know, it's an area of strength in Canada. Canada has some of the top researchers in the world in the field of neuroscience. We have international repute in that area, and CIHR spends a significant amount of money on that. We're talking about ongoing yearly spending of over

June 15th, 2010Committee meeting

Dr. Alain Beaudet

Health committee  Thank you for the question. As you know, it's very important to understand where research is needed, what the gaps are in our knowledge, and particularly what relates to the relationship between cerebrovascular events and MS, including cerebrospinal venous insufficiency, but not

June 15th, 2010Committee meeting

Dr. Alain Beaudet

Health committee  First, I perhaps would like to address the question of aboriginal health, because I agree with you that it's a very serious issue. One of the reasons for that seriousness is that very often we don't exactly know how to tackle these issues. As you know, one of the five prioritie

June 15th, 2010Committee meeting

Dr. Alain Beaudet

Health committee  With regard to the question regarding maternal health, it also is an area that, as you know, we at CIHR are looking at. Our institute of maternal health and child development is focused on that issue. As you know, we look at each proposed project on its merit, on the basis of e

June 15th, 2010Committee meeting

Dr. Alain Beaudet

Health committee  If I may, council unanimously approved the nomination of Mr. Prigent. It was welcomed unanimously by council as fulfilling a need.

November 30th, 2009Committee meeting

Dr. Alain Beaudet

Health committee  Certainly. Actually, I can even recommend excellent reading, which is the strategic plan of CIHR that was just launched a few weeks ago, where our priorities are very clearly outlined. Without going into a large presentation of our strategic plan, I'll just insist on impartialit

November 30th, 2009Committee meeting

Dr. Alain Beaudet

Health committee  The letter of support you have is a letter of support by the governing council, signed by all members.

November 30th, 2009Committee meeting

Dr. Alain Beaudet

Health committee  Perhaps the other letter was not distributed. There was a letter written to this committee, I think, sent to you on behalf of all members of the governing council.

November 30th, 2009Committee meeting

Dr. Alain Beaudet

Health committee  Thank you. Clearly what they say is that, after a careful gap analysis, what was glaringly missing in terms of expertise on the council—because we do have experts in public health, experts in global health, experts in basic research, experts in applied research, and experts in h

November 30th, 2009Committee meeting

Dr. Alain Beaudet

Health committee  First of all, I'd like to reiterate that Dr. Prigent is not representing Pfizer. Actually, if he was representing Pfizer, the outcry wouldn't be from the community; it would be from all the pharmaceutical companies that would also want to have a representative. Dr. Prigent is r

November 30th, 2009Committee meeting

Dr. Alain Beaudet

Health committee  First of all, I can only state what I know. I know for a fact that there's a heavy presence in the U.K. on the board of MRC of the biopharmaceutical sector, and I must say that they are fairly successful at curbing the trend and doing things differently in terms of innovation and

November 30th, 2009Committee meeting

Dr. Alain Beaudet

Health committee  Correct.

November 30th, 2009Committee meeting

Dr. Alain Beaudet

Health committee  I can definitely do that. First of all, I would like to go back to the question from your colleague Ms. Bennett. In fact, they are all potentially in conflict of interest. There is a vice-president for research. Is he speaking for his university? Should we have former vice-pres

November 30th, 2009Committee meeting

Dr. Alain Beaudet

Health committee  Thank you, Madam Chair. I'm pleased to appear before you as part of the review of Dr. Prigent's recent appointment to the CIHR governing council. Let me tell you right at the outset how much CIHR's governing council and I personally welcome and support this superb addition to ou

November 30th, 2009Committee meeting

Dr. Alain Beaudet

Health committee  Now then, the first part of your question refers more or less to what you just asked regarding the breadth of vision. With regard to research, we are talking about competitiveness at the national level, about combining our resources and establishing uniform standards of practice

April 23rd, 2009Committee meeting

Alain Beaudet